INMB
INmune Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.44
+7.49%Leverage
- Debt / equity
- 0.07x
- Net debt / equity
- -0.84x
- Debt / assets
- 0.05x
- Debt / EBITDA
- -0.08x
- Net debt / EBITDA
- 0.93x
Liquidity & coverage
- Current ratio
- 4.04x
- Quick ratio
- 4.04x
- Cash ratio
- 3.13x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $17.9M
Cash & dividend
- FCF / debt
- -11.60x
- Cash flow / debt
- -10.66x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026